🏥 Калькулятор Метаболического Синдрома

Нормальные референсные диапазоны

• Нормальный ИМТ: 18.5-24.9 кг/м²
• Нормальная глюкоза натощак: <100 мг/дл (5.6 ммоль/л)
• Нормальное артериальное давление: <120/80 мм рт. ст.
• Нормальные триглицериды: <150 мг/дл (1.7 ммоль/л)
• Нормальный холестерин ЛПВП (Мужчины): ≥40 мг/дл (1.0 ммоль/л)
• Нормальный холестерин ЛПВП (Женщины): ≥50 мг/дл (1.3 ммоль/л)
• Нормальная окружность талии (Мужчины): <94 см (европейцы)
• Нормальная окружность талии (Женщины): <80 см (европейцы)

Используемые клинические рекомендации

1. World Health Organization (1999). Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. WHO/NCD/NCS/99.2.
2. International Diabetes Federation (2006). The IDF Consensus Worldwide Definition of the Metabolic Syndrome. Central European University Press.
3. International Diabetes Federation (2017). IDF Diabetes Atlas, 8th edition. Brussels, Belgium.
4. National Cholesterol Education Program (NCEP) Expert Panel (2002). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Circulation, 106(25), 3143-3421.
5. American Heart Association/National Heart, Lung, and Blood Institute (2005). Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation, 112(17), 2735-2752.
6. World Health Organization (2021). WHO guidelines on physical activity and sedentary behaviour.

Ключевые научные статьи

1. Alberti KG, Zimmet P, Shaw J (2006). Metabolic syndrome—a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabetic Medicine, 23(5), 469-480.
2. Alberti KGMM, Eckel RH, Grundy SM, et al. (2009). Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation, 120(16), 1640-1645.
3. Reaven GM (1988). Banting lecture 1988: Role of insulin resistance in human disease. Diabetes, 37(12), 1595-1607.
4. Kahn R, Buse J, Ferrannini E, Stern M (2005). The Metabolic Syndrome: Time for a Critical Appraisal: Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care, 28(9), 2289-2304.
5. Lakka HM, Laaksonen DE, Lakka TA, et al. (2002). The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA, 288(21), 2709-2716.
6. Mottillo S, Filion KB, Genest J, et al. (2010). The metabolic syndrome and cardiovascular risk: A systematic review and meta-analysis. Journal of the American College of Cardiology, 56(14), 1113-1132.
7. Gami AS, Witt BJ, Howard DE, et al. (2007). Metabolic syndrome and risk of incident cardiovascular events and death: A systematic review and meta-analysis. Journal of the American College of Cardiology, 49(4), 403-410.